Abstract: The present invention relates to stable long acting inhalation composition comprising indacaterol or its acceptable salts at a concentration from about 15 mcg/mL up to about 150 mcg/mL, and optionally comprising one or more anticholinergic agent. It also relates to use of such compositions for the prevention and/or treatment of respiratory, inflammatory or chronic obstructive airway disease (CORD).
| # | Name | Date |
|---|---|---|
| 1 | 202147037563-FORM 18 [19-08-2021(online)].pdf | 2021-08-19 |
| 2 | 202147037563-FORM 1 [19-08-2021(online)].pdf | 2021-08-19 |
| 3 | 202147037563-COMPLETE SPECIFICATION [19-08-2021(online)].pdf | 2021-08-19 |
| 4 | 202147037563.pdf | 2021-10-19 |
| 5 | 202147037563-FER.pdf | 2021-11-15 |
| 6 | 202147037563-FORM 3 [30-12-2021(online)].pdf | 2021-12-30 |
| 7 | 202147037563-ENDORSEMENT BY INVENTORS [30-12-2021(online)].pdf | 2021-12-30 |
| 8 | 202147037563-OTHERS [12-05-2022(online)].pdf | 2022-05-12 |
| 9 | 202147037563-FER_SER_REPLY [12-05-2022(online)].pdf | 2022-05-12 |
| 10 | 202147037563-CORRESPONDENCE [12-05-2022(online)].pdf | 2022-05-12 |
| 11 | 202147037563-COMPLETE SPECIFICATION [12-05-2022(online)].pdf | 2022-05-12 |
| 12 | 202147037563-CLAIMS [12-05-2022(online)].pdf | 2022-05-12 |
| 13 | 202147037563-US(14)-HearingNotice-(HearingDate-06-02-2024).pdf | 2023-12-07 |
| 14 | 202147037563-Written submissions and relevant documents [15-02-2024(online)].pdf | 2024-02-15 |
| 15 | 202147037563-Annexure [15-02-2024(online)].pdf | 2024-02-15 |
| 16 | 202147037563-Written submissions and relevant documents [16-02-2024(online)].pdf | 2024-02-16 |
| 17 | 202147037563-Written submissions and relevant documents [20-02-2024(online)].pdf | 2024-02-20 |
| 18 | 202147037563-FORM-26 [20-02-2024(online)].pdf | 2024-02-20 |
| 19 | 202147037563-Written submissions and relevant documents [21-02-2024(online)].pdf | 2024-02-21 |
| 20 | 202147037563-PatentCertificate22-02-2024.pdf | 2024-02-22 |
| 21 | 202147037563-IntimationOfGrant22-02-2024.pdf | 2024-02-22 |
| 1 | search11112021E_11-11-2021.pdf |